Showing 1 - 8 results of 8 for search 'Ari J. Rosenberg', query time: 0.04s
Refine Results
-
1
-
2
Doublecortin-Like Kinase 1 (DCLK1) Is a Novel NOTCH Pathway Signaling Regulator in Head and Neck Squamous Cell Carcinoma by Esther C. Broner, Jonathan A. Trujillo, Michael Korzinkin, Tejaswini Subbannayya, Nishant Agrawal, Ivan V. Ozerov, Alex Zhavoronkov, Lisa Rooper, Nikita Kotlov, Le Shen, Alexander T. Pearson, Ari J. Rosenberg, Peter A. Savage, Vasudha Mishra, Aditi Chatterjee, Aditi Chatterjee, Aditi Chatterjee, David Sidransky, Evgeny Izumchenko
Published 2021-07-01
Article -
3
AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling by Renata Ferrarotto, Vasudha Mishra, Elad Herz, Adar Yaacov, Oz Solomon, Rami Rauch, Adi Mondshine, Maria Motin, Tal Leibovich-Rivkin, Matti Davis, Joel Kaye, Christopher R. Weber, Le Shen, Alexander T. Pearson, Ari J. Rosenberg, Xiangying Chen, Alka Singh, Jon C. Aster, Nishant Agrawal, Evgeny Izumchenko
Published 2022-08-01
Article -
4
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer by Thomas F. Cyberski, Alka Singh, Michael Korzinkin, Vasudha Mishra, Frank Pun, Le Shen, Claudia Wing, Xiangying Cheng, Brandon Baird, Yuxuan Miao, Moshe Elkabets, Sara Kochanny, Wenji Guo, Emma Dyer, Alexander T. Pearson, Aditya Juloori, Mark Lingen, Grayson Cole, Alex Zhavoronkov, Nishant Agrawal, Evgeny Izumchenko, Ari J. Rosenberg
Published 2024-05-01
Article -
5
679 Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or lat... by Siqing Fu, Rom S Leidner, Ki Chung, Jiaxin Niu, Ilian Tchakov, Debra L Richardson, Xiaoping Qing, Jorge Nieva, Douglas Adkins, Alan L Ho, Minh Phan, Alexander T Pearson, Marshall R Posner, Lisle Nabell, Stuart Wong, Katerin Rojas, Ari J Rosenberg, Trisha Kaufmann, Christopher Plescia, Corinne Iacobucci, Kia Katchar, Klaus Orlinger, Katia Schlienger, David G Pfister
Published 2023-11-01Article -
6
A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer by Manijeh Goldberg, Aaron Manzi, Peter Conway, Stefanie Cantin, Vasudha Mishra, Alka Singh, Alexander T. Pearson, Eric R. Goldberg, Sam Goldberger, Benjamin Flaum, Rifat Hasina, Nyall R. London, Gary L. Gallia, Chetan Bettegowda, Sonya E. O’Neill, Erkin Aydin, Alex Zhavoronkov, Anxo Vidal, Atenea Soto, Maria Jose Alonso, Ari J. Rosenberg, Mark W. Lingen, Anil D’Cruz, Nishant Agrawal, Evgeny Izumchenko
Published 2022-08-01
Article -
7
PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands by Vasudha Mishra, Alka Singh, Michael Korzinkin, Xiangying Cheng, Claudia Wing, Viktoria Sarkisova, Ashwin L. Koppayi, Alexandra Pogorelskaya, Oksana Glushchenko, Manu Sundaresan, Venkat Thodima, Jack Carter, Koichi Ito, Peggy Scherle, Anna Trzcinska, Ivan Ozerov, Everett E. Vokes, Grayson Cole, Frank W. Pun, Le Shen, Yuxuan Miao, Alexander T. Pearson, Mark W. Lingen, Bruce Ruggeri, Ari J. Rosenberg, Alex Zhavoronkov, Nishant Agrawal, Evgeny Izumchenko
Published 2025-01-01
Article -
8
Author Correction: A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer by Manijeh Goldberg, Aaron Manzi, Amritpreet Birdi, Brandon Laporte, Peter Conway, Stefanie Cantin, Vasudha Mishra, Alka Singh, Alexander T. Pearson, Eric R. Goldberg, Sam Goldberger, Benjamin Flaum, Rifat Hasina, Nyall R. London, Gary L. Gallia, Chetan Bettegowda, Simon Young, Vlad Sandulache, James Melville, Jonathan Shun, Sonya E. O’Neill, Erkin Aydin, Alex Zhavoronkov, Anxo Vidal, Atenea Soto, Maria Jose Alonso, Ari J. Rosenberg, Mark W. Lingen, Anil D’Cruz, Nishant Agrawal, Evgeny Izumchenko
Published 2022-12-01
Article